Skip to main content

Jeffrey Edwards, Arnold Pinkston, Gregory Hinckley

Bio-Rad has elected three new board members — Jeffrey Edwards, Gregory Hinckley, and Arnold Pinkston — at its annual shareholders meeting. 

Jeffrey Edwards previously served as CEO of Allergan from 2005 to August 2014, and retired from the company in 2015 after 22 years

Arnold Pinkston previously served as executive vice president and general counsel for Allergan, senior vice president and general counsel for Beckman Coulter, and vice president and deputy general counsel at Eli Lilly.

Gregory Hinckley currently serves as president of Mentor Graphics, a supplier of products and services used for the design of electronic content, and has 30 years of public company experience.

The newly-elected members replace Louis Drapeau, Robert Malchione, Joel McComb and Deborah Neff, who declined to stand for reelection due to disagreements with Bio-Rad's management regarding executive personnel and corporate governance matters, according to a Securities and Exchange Commission filing. In a statement, Bio-Rad noted that their decision not to stand for reelection was not related to any issues regarding the integrity of the company's financial statements or accounting policies and practices.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.